Alpha Cognition Inc ACOGF

Primary Symbol: C.ACOG

Healthcare Biotechnology

Alpha Cognition Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is engaged in developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease and Cognitive Impairment with mild Traumatic Brain Injury (mTBI). The Company’s pipeline includes ALPHA-1062, ALPHA-0602, and ALPHA-0702 and ALPHA-0802 (GEMs). The Company’s ALPHA-1062 is a patented new chemical entity being developed as a new generation acetylcholinesterase inhibitor for the treatment of Alzheimer's disease, with expected minimal gastrointestinal side effects. ALPHA-1062 is also being developed in combination with memantine to treat moderate to severe Alzheimer’s dementia, and as an intranasal formulation for Cognitive Impairment with mTBI. ALPHA-0602 is a gene therapy program delivering progranulin, a neurotrophic protein. It is in preclinical development for the treatment of ALS.

CSE:ACOG - Post by User

Alpha Cognition Inc

<< Previous

Bullboard Posts

Next >>

Post by retiredcfon Jan 12, 2022 7:03am

97 Views

Post# 34306917

Top Gainers

Essentially meaningless given the trading volume but better up than down. GLTA

Symbol/ Company	Price $	Change $	Volume
Data delayed at least 15 minutes, as of 11/01/2022 3:59 PM ET \| All market data delayed
GAME Engine Gaming and Media Inc	$3.95 CAD	+$0.53(15.50%)	9.97K
XYBN Xybion Digital Inc	$3.00 CAD	+0.29(10.70%)	6.35K
CERT Cerrado Gold Corp	$1.58 CAD	+0.15(10.49%)	39.03K
REG Regulus Resources Inc	$1.10 CAD	+0.10(10.00%)	37.00K
BITF Bitfarms Ltd	$5.93 CAD	+0.52(9.61%)	1.06M
SVA Sernova Corp	$1.70 CAD	+0.14(8.97%)	1.45M
ACOG Alpha Cognition Inc	$1.12 CAD	+0.09(8.74%)	4.90K